Výsledky vyhledávání - "Edgar B. Smith"

The safety of terbinafine in patients over the age of 60 years: a multicenter trial in onychomycosis of the feet

Autor: Edgar B. Smith, Ercem S. Atillasoy, David P. Fivenson, Linda F. Stein

Publikováno v: International Journal of Dermatology. 39:861-864

Thirty patients completed this open-label, multicenter prospective study performed to evaluate the efficacy and safety of terbinafine treatment of onychomycosis of the feet in elderly patients. Inclusion criteria included an age of 60 years or older,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1b848d5ad5b409b986f68fc1c1a998e2
https://doi.org/10.1046/j.1365-4362.2000.00087-2.x

Zobrazit plný text záznamu

Patient personal injury litigation against dermatology residency programs in the United States, 1964-1988. Implications for future risk-management programs in dermatology and dermatologic surgery

Autor: Eric S. Hollabaugh, Victor W. Weedn, Richard F. Wagner, Edgar B. Smith

Publikováno v: Archives of Dermatology. 126:618-622

• A national survey reviewing patient injury litigation against US dermatology residency programs revealed that 50% of the respondents had experienced at least one lawsuit between 1964 and 1988. The northeast region reported the most legal activity

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c16266bcc28189d5b85e053693e835fc
https://doi.org/10.1001/archderm.126.5.618

Zobrazit plný text záznamu

Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis

Autor: John Sefton, Ronald E. DeGryse, Edgar B. Smith, Debra L. Breneman, Russell F. Griffith, Frank P. Killey, J. Michael Maloney, Adelaide A. Hebert, Virginia I. Sulica, Larry E. Millikan, Janet G. Hickman, Sydney H. Dromgoole

Publikováno v: Journal of the American Academy of Dermatology. 26:125-127

chenoid infiltrate of lymphocytes. Immunofluorescence examination of a perivesicular papule was characterized by numerous ovoid bodies scattered in the papillary dermis. These stained for IgM, IgG, and fibrinogen. IgG, C3, and fibrinogen were also de

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6276d5933eba29afba25c7775123708c
https://doi.org/10.1016/s0190-9622(08)80528-2

Zobrazit plný text záznamu

History of antifungals

Autor: Edgar B. Smith

Publikováno v: Journal of the American Academy of Dermatology. 23:776-778

Until two to three decades ago, only a few drugs were available for the treatment of fungal infections. The status of antifungal therapy changed dramatically in the late 1960s with the introduction of newer broader spectrum agents, such as the iodina

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bf83a6e71f2145c87a9f17cd6b5b887
https://doi.org/10.1016/0190-9622(90)70286-q

Zobrazit plný text záznamu

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail

Autor: Phoebe Rich, David S. Feingold, Nicholas J. Lowe, Jerome L. Shupack, Eduardo Tschen, Richard K. Scher, Nellie Konnikov, Norman Levine, Edgar B. Smith, Alicia D. Bucko, Donald L. Greer, Richard B. Odom, Debra Breneman, Raza Aly, Boni E. Elewski, Manuel R. Morman, Ronald C. Savin, Sheldon Pinnell

Publikováno v: Journal of the American Academy of Dermatology. 38(6 Pt 2)

Onychomycosis is a prevalent infection of the nail caused primarily by dermatophytes. Fluconazole is active in vitro against the most common pathogens of onychomycosis, penetrates into the nail bed, and is clinically effective in the treatment of a w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8e527e567f7c13efd9ef06fa13e8856
https://pubmed.ncbi.nlm.nih.gov/9631989

Zobrazit plný text záznamu

Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail

Autor: Debra L. Breneman, James Hilbert, Nicholas J. Lowe, Nellie Konnikov, Manuel R. Morman, Donald L. Greer, Ronald C. Savin, Norman Levine, Alicia D. Bucko, Sheldon R. Pinnell, Raza Aly, David S. Feingold, Edgar B. Smith, Jerome L. Shupack, Boni E. Elewski, Richard K. Scher, Phoebe Rich, Eduardo Tschen, Richard B. Odom

Publikováno v: Journal of the American Academy of Dermatology. 38(6 Pt 2)

Background: Preliminary clinical data suggest that fluconazole is effective in the treatment of patients with onychomycosis. To design optimum dosage regimens, a better understanding of fluconazole's distribution into and elimination from nails is ne

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91c174eb8460f2f3e764fe6801b57f85
https://pubmed.ncbi.nlm.nih.gov/9631992

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání